Aimovig Priced ‘Well Below’ Part D Specialty Threshold To Avoid Coinsurance
Amgen-Novartis pricing strategy seeks to ensure patients are subject to flat copays rather than coinsurance, which is calculated as a percentage of drug's list price.
Amgen-Novartis pricing strategy seeks to ensure patients are subject to flat copays rather than coinsurance, which is calculated as a percentage of drug's list price.